To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease (NCT04134299) | Axcella Health, Inc | 2019-09-25 |
Track To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease automatically
Every clearance here is in the API, with alerts when new ones post.